加入收藏 欢迎光临Abbkine Scientific Co., Ltd官方网站全国服务热线:400-6800-830
登录 注册
中文

亚科因(Abbkine)—服务于细胞和蛋白研究全球用户

货号 产品名称 文献标题 IF 杂志名称
A23210 山羊抗小鼠IgG二抗, 绿色DyLight 488荧光标记 Roflupram alleviates autophagy defects and reduces mutant hSOD1-induced motor neuron damage in cell and mouse models of amyotrophic lateral sclerosis 5 Neuropharmacology
A23210 山羊抗小鼠IgG二抗, 绿色DyLight 488荧光标记 The discrepancy distribution of macrophage subsets in preeclampsia placenta with or without fetal growth restriction from a small cohort 1 Ginekologia Polska
A23210 山羊抗小鼠IgG二抗, 绿色DyLight 488荧光标记 Red recombination enables a wide variety of markerless manipulation of porcine epidemic diarrhea virus genome to generate recombinant virus 6 Frontiers in Cellular and Infection Microbiology
A23210 山羊抗小鼠IgG二抗, 绿色DyLight 488荧光标记 A novel sorbicillinoid compound as a potent anti‐inflammation agent through inducing NLRP3 protein degradation 7 British Journal of Pharmacology
A23210 山羊抗小鼠IgG二抗, 绿色DyLight 488荧光标记 Establishment and characterization of a carcinoma-associated fibroblast cell line derived from a human salivary gland adenoid cystic carcinoma 2 Cell Communication & Adhesion
A23210 山羊抗小鼠IgG二抗, 绿色DyLight 488荧光标记 Hyperforin improves post-stroke social isolation‑induced exaggeration of PSD and PSA via TGF-β. 3 Int J Mol Med
A23210 山羊抗小鼠IgG二抗, 绿色DyLight 488荧光标记 USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis 6 Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease
A23210 山羊抗小鼠IgG二抗, 绿色DyLight 488荧光标记 NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer 12 Nature Communications
A23210 山羊抗小鼠IgG二抗, 绿色DyLight 488荧光标记 Treatment of donor cells with recombinant KDM4D protein improves preimplantation development of cloned ovine embryos 2 Cytotechnology
A23210 山羊抗小鼠IgG二抗, 绿色DyLight 488荧光标记 Feasibility study on epithelial cells regeneration after excising the demucosalized ileum for ureteral reconstructive surgery 5 The FASEB Journal 
意见反馈
在线咨询
扫码关注

微信公众号

返回顶部